IP Library › Assignment 069095/0329
Patent Assignment
Reel/Frame 069095/0329

Change of Name

Recorded: 2024-10-01 Pages: 4
Assignor
Assignee
SUMITOMO PHARMA ONCOLOGY, INC.
640 MEMORIAL DRIVE, CAMBRIDGE, MASSACHUSETTS, 02139
Covered Property (1)
Pim Kinase Inhibitors for Treatment of Myeloproliferative Neoplasms and Fibrosis Associated with Cancer
Application: 18/743,075 →
Related Assignments (5)
Other recorded transfers of the patent in this record — the chain of ownership.
Merger Sep 18, 2024
From: SUMITOMO PHARMA ONCOLOGY, INC.
To: SUMITOMO PHARMA AMERICA, INC.
Reel/Frame 068618/0375 →
Assignment of Assignor's Interest Oct 1, 2024
From: FOULKS, JASON MARC; WARNER, STEVEN L.
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 069094/0174 →
Change of Name Oct 1, 2024
From: BOSTON BIOMEDICAL, INC.
To: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
Reel/Frame 069094/0181 →
Merger Oct 1, 2024
From: TOLERO PHARMACEUTICALS, INC.
To: BOSTON BIOMEDICAL, INC.
Reel/Frame 068757/0850 →
Merger Oct 1, 2024
From: SUMITOMO PHARMA ONCOLOGY, INC.
To: SUMITOMO PHARMA AMERICA, INC.
Reel/Frame 068757/0957 →